The 4 analysts offering 12-month price forecasts for Minerva Neurosciences Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +197.62% increase from the last price of 2.52.
The current consensus among 5 polled investment analysts is to Buy stock in Minerva Neurosciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.33
Reporting Date May 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.